Cargando…
Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the prot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109846/ https://www.ncbi.nlm.nih.gov/pubmed/35603079 http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10 |
_version_ | 1784708967512932352 |
---|---|
author | Zhou, Xiangmei Richards, Philip Windhorst, Daniel Imre, Ariel Bukovinski, Agnes Ruggeri, Jessica Elazomi, Altayeb Barrow, Paul |
author_facet | Zhou, Xiangmei Richards, Philip Windhorst, Daniel Imre, Ariel Bukovinski, Agnes Ruggeri, Jessica Elazomi, Altayeb Barrow, Paul |
author_sort | Zhou, Xiangmei |
collection | PubMed |
description | BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the proteins expressed during infection of antigen-presenting cells. AIM: The aim was to produce a more protective inactivated vaccine by culturing the avian E. coli in a synthetic medium that resembled the environment of the phagolysosome. METHODS: Global gene expression in a pathogenic avian O78:K80 strain of E. coli, harvested from infected avian macrophage-like HD11 cells, was compared by microarray with bacteria cultured in a tissue culture medium. A liquid synthetic medium was produced based on the environmental conditions identified to which the bacteria were exposed intracellularly. A bacterin was produced from this strain and its protective ability was assessed in chickens. RESULTS: The changes in E. coli gene expression observed included the use of different electron acceptors and carbon sources such as ethanolamine, β-glucosides, galactonate, dicarboxylic acids, and amino acids, up-regulation of genes associated with Fe and Mn uptake, and up-regulation of type-1 and curli fimbriae, other adhesion genes and down-regulation of sialic acid synthesis genes. The bacterin produced in the synthetic medium was statistically more protective than a bacterin prepared from bacteria cultured in the nutrient broth when tested in vaccinated chickens challenged with a different virulent E. coli O78:K80 strain. CONCLUSION: The approach of using gene expression to produce synthetic media for the generation of more effective bacterins could be used for a number of intracellular bacteria pathogens including Enteroinvasive E. coli, Salmonella, and the Pasteurella/Riemerella/Mannheimia group of organisms. |
format | Online Article Text |
id | pubmed-9109846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Faculty of Veterinary Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-91098462022-05-21 Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design Zhou, Xiangmei Richards, Philip Windhorst, Daniel Imre, Ariel Bukovinski, Agnes Ruggeri, Jessica Elazomi, Altayeb Barrow, Paul Open Vet J Original Research BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the proteins expressed during infection of antigen-presenting cells. AIM: The aim was to produce a more protective inactivated vaccine by culturing the avian E. coli in a synthetic medium that resembled the environment of the phagolysosome. METHODS: Global gene expression in a pathogenic avian O78:K80 strain of E. coli, harvested from infected avian macrophage-like HD11 cells, was compared by microarray with bacteria cultured in a tissue culture medium. A liquid synthetic medium was produced based on the environmental conditions identified to which the bacteria were exposed intracellularly. A bacterin was produced from this strain and its protective ability was assessed in chickens. RESULTS: The changes in E. coli gene expression observed included the use of different electron acceptors and carbon sources such as ethanolamine, β-glucosides, galactonate, dicarboxylic acids, and amino acids, up-regulation of genes associated with Fe and Mn uptake, and up-regulation of type-1 and curli fimbriae, other adhesion genes and down-regulation of sialic acid synthesis genes. The bacterin produced in the synthetic medium was statistically more protective than a bacterin prepared from bacteria cultured in the nutrient broth when tested in vaccinated chickens challenged with a different virulent E. coli O78:K80 strain. CONCLUSION: The approach of using gene expression to produce synthetic media for the generation of more effective bacterins could be used for a number of intracellular bacteria pathogens including Enteroinvasive E. coli, Salmonella, and the Pasteurella/Riemerella/Mannheimia group of organisms. Faculty of Veterinary Medicine 2022 2022-04-04 /pmc/articles/PMC9109846/ /pubmed/35603079 http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Zhou, Xiangmei Richards, Philip Windhorst, Daniel Imre, Ariel Bukovinski, Agnes Ruggeri, Jessica Elazomi, Altayeb Barrow, Paul Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title | Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title_full | Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title_fullStr | Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title_full_unstemmed | Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title_short | Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design |
title_sort | generation of an inactivated vaccine for avian pathogenic escherichia coli using microarrays: a more rational approach to inactivated vaccine design |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109846/ https://www.ncbi.nlm.nih.gov/pubmed/35603079 http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10 |
work_keys_str_mv | AT zhouxiangmei generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT richardsphilip generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT windhorstdaniel generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT imreariel generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT bukovinskiagnes generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT ruggerijessica generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT elazomialtayeb generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign AT barrowpaul generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign |